First Quadrant’s CareDx CDNA Stock Holding History

First Quadrant’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-694	Closed	-$15K	–	728
2020 Q1	$15K	Buy	+694	New	+$15.6K	﹤0.01%	606
2019 Q3	–	Sell	-1,740	Closed	-$63K	–	597
2019 Q2	$63K	Buy	+1,740	New	+$55.7K	﹤0.01%	615

Other funds holding CDNA

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

First Quadrant's CDNA Position: Q2 2020 in Review

First Quadrant sold out of CareDx (CDNA) in Q2 2020, closing a stake of 694 shares — an estimated $15K sold.

First Quadrant first reported a position in CDNA in Q2 2019 and held it in 2 quarters. The position peaked at $63K in Q2 2019. 189 funds tracked by Wall St. Rank hold CDNA as of Q2 2020.

First Quadrant reported no remaining CareDx position as of Q2 2020 after selling out during the quarter.
First Quadrant sold 694 CareDx shares in Q2 2020, an estimated $15K.
First Quadrant first reported a position in CareDx in Q2 2019 and held it in 2 quarters.
First Quadrant's CareDx position peaked at $63K in Q2 2019.
189 funds tracked by Wall St. Rank held CareDx as of Q2 2020.

Based on First Quadrant's 13F filing for Q2 2020, filed 28 Jul 2020.